CLINICAL_TRIALS
trial_result
· 2018-11-23
Clinical Trial Update: Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants [Phase 3]
Summary
Phase 3 trial update on erythropoietin for repairing cerebral injury in very preterm infants with intraventricular hemorrhage of prematurity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Intraventricular Hemorrhage of Prematurity | Phase 3 | Status: UNKNOWN